Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research

Journal of Studies on Alcohol and Drugs

Volumn 69, Issue 5, 2008, Pages 757-764

  Humphreys, Keith ^a,b   Harris, Alex H S ^a,b   Weingardt, Kenneth R ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL REHABILITATION PROGRAM; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTIVATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; SENSITIVITY ANALYSIS; SOCIAL ASPECT; TREATMENT OUTCOME; CLINICAL PROTOCOL; CLINICAL TRIAL; EPIDEMIOLOGY; METHODOLOGY; PATIENT SELECTION; STANDARD;

ALCOHOLISM; BIAS (EPIDEMIOLOGY); CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 54049093650     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2008.69.757     Document Type: Article

References (20)

1. BLANCO, C., OLFSON, M., OKUDA, M., NUNES, E.V., LIU, S.-M., AND HASIN, D.S. Generalizability of clinical trials for alcohol dependence to community samples, submitted for publication.
2. BOVASSO, G.B., ALTERMAN, A.I., CACCIOLA, J.S., AND COOK, T.G. Predictive validity of the Addiction Severity Index's composite scores in the assessment of 2-year outcomes in a methadone maintenance program. Psychol. Addict. Behav. 15: 171-176, 2001.
3. CARNEY, M., DONOVAN, D., WEAVER, K., AND BARGOIL, D. Washington State Outcomes Project: An Evaluation of the Publicly Funded Adult Residential Treatment System in Washington State, Management Report, Olympia, WA: Department of Alcohol and Substance Abuse, Washington State, 2000.
4. DEVINE, J.A., BRODY, C.J., AND WRIGHT, J.D. Evaluating an alcohol and drug treatment program for the homeless: An econometric approach. Eval. Prog. Plann. 20: 205-215, 1997.
5. GUYDISH, J. AND CLAUS, R.E. Improving publicly-funded drug abuse treatment systems: The Target Cities Initiative. J. Psychoact. Drugs 34: 1-6, 2002.
6. HLATKY, M.A., LEE, K.L., HARRELL, F.E., JR., CALIFF, R.M., PRYOR, D.B., MARK, D.B., AND ROSATI, R.A. Tying clinical research to patient care by use of an observational database. Stat. Med. 3: 375-387, 1984.
7. HUMPHREYS, K. Datapoints: Do participants in alcoholism treatment outcome studies resemble patients seen in everyday practice? Psychiat. Serv. 54: 1576, 2003.
8. HUMPHREYS, K., WEINGARDT, K.R., AND HARRIS, A.H.S. Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities and children in treatment research. Alcsm Clin. Exp. Res. 31: 988-995, 2007.
9. HUMPHREYS, K., WEINGARDT, K.R., HORST, D., JOSHI, A.A., AND FINNEY, J.W. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-1998. Addiction 100: 1249-1257, 2005.
10. HUMPHREYS, K. AND WEISNER, C. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Amer. J. Psychiat. 157: 588-594, 2000.
11. LIPSEY, M.W. Design Sensitivity: Statistical Power for Experimental Research, Thousand Oaks, CA: Sage, 1990.
12. MCLELLAN, A.T., LUBORSKY, L., CACCIOLA, J., GRIFFITH, J., EVANS, F., BARR, H.L., AND O'BRIEN, C.P. New data from the Addiction Severity Index: Reliability and validity in three centers. J. Nerv. Ment. Dis. 173: 412-423, 1985.
13. MCLELLAN, A.T., LUBORSKY, L., WOODY, G.E., AND O'BRIEN, C.P. An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. J. Nerv. Ment. Dis. 168: 26-33, 1980.
14. MARTIN, J.F., HENDERSON, W.G., ZACHARSKI, L.R., RICKLES, F.R., FORMAN, W.B., CORNELL, C.J., JR., FORCIER, R.J., EDWARDS, R.L., HEADLEY, E., KIM, S.-H., O'DONNELL, J.F., ODELL, R., TORNYOS, K., AND KWAAN, H.C. Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies. Amer. J. Clin. Oncol. 7: 173-182, 1984.
15. MAVISSAKALIAN, M.R. AND GUO, S. Predictors of entering a long-term drug treatment study of panic disorder. Comprehen. Psychiat. 43: 88-94, 2002.
16. MONCRIEFF, J. AND DRUMMOND, D.C. The quality of alcohol treatment research: An examination of influential controlled trials and development of a quality rating system. Addiction 93: 811-823, 1998.
17. PETO, R., COLLINS, R., AND GRAY, R. Large-scale randomized evidence: Large, simple trials and overviews of trials. Ann. N.Y. Acad. Sci. 703: 314-340, 1993.
18. SCHNEIDER, L.S., OLIN, J.T., LYNESS, S.A., AND CHUI, H.C. Eligibility of Alzheimer's disease clinic patients for clinical trials. J. Amer. Geriat. Soc. 45: 923-928, 1997.
19. SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (Office of Applied Studies). Treatment Episode Data Set (TEDS), Highlights-2004: National Admissions to Substance Abuse Treatment Services, DHHS Publication No. (SMA) 06-4140, Rockville, MD: Substance Abuse and Mental Health Services Administration, 2006.
20. VAN SPALL, H.G.C., TOREN, A., KISS, A., AND FOWLER, R.A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. JAMA 297: 1233-1240, 2007.